Global Generic Drugs Sales Market Report 2017

ジェネリック医薬品の世界市場:販売動向2017

◆タイトル:Global Generic Drugs Sales Market Report 2017
◆商品コード:QYR7052211
◆調査・発行会社:QYResearch
◆発行日:2014年5月3日
◆ページ数:124
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、ジェネリック医薬品の世界市場について調査・分析し、ジェネリック医薬品のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、ジェネリック医薬品産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・ジェネリック医薬品市場概要
・ジェネリック医薬品のメーカー別販売量・メーカー別シェア
・ジェネリック医薬品の世界市場:種類別販売量・市場シェア
・ジェネリック医薬品の世界市場:用途別販売量・市場シェア
・ジェネリック医薬品の世界市場:地域別販売量・市場シェア
・ジェネリック医薬品のアメリカ市場規模
・ジェネリック医薬品の中国市場規模
・ジェネリック医薬品のヨーロッパ市場規模
・ジェネリック医薬品の日本市場規模
・ジェネリック医薬品の東南アジア市場規模
・ジェネリック医薬品のインド市場規模
・ジェネリック医薬品のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・ジェネリック医薬品のコスト分析・価格動向
・ジェネリック医薬品の産業チェーン(サプライチェーン分析)
・ジェネリック医薬品のマーケティング戦略・販売チャネル、流通業者
・ジェネリック医薬品市場への影響要因分析
・ジェネリック医薬品の世界市場予測
・ジェネリック医薬品のアメリカ市場予測
・ジェネリック医薬品の中国市場予測
・ジェネリック医薬品のヨーロッパ市場予測
・ジェネリック医薬品の日本市場予測
・ジェネリック医薬品の東南アジア市場予測
・ジェネリック医薬品のインド市場予測
・ジェネリック医薬品の種類別世界市場予測
・ジェネリック医薬品の用途別世界市場予測
...

In this report, the global Generic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Generic Drugs for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Generic Drugs market competition by top manufacturers/players, with Generic Drugs sales volume, Price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Teva Pharma
Novartis-Sandoz
Mylan
Sun Pharmaceutical
Aspen Pharmacare
Allergan
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy’s Lab
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Simple Generic Drugs
Super Generic Drugs
Biosimilars
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Generic Drugs for each application, including
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Rheumatology
Oncology

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Generic Drugs Sales Market Report 2017
1 Generic Drugs Market Overview
1.1 Product Overview and Scope of Generic Drugs
1.2 Classification of Generic Drugs by Product Category
1.2.1 Global Generic Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Generic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Simple Generic Drugs
1.2.4 Super Generic Drugs
1.2.5 Biosimilars
1.3 Global Generic Drugs Market by Application/End Users
1.3.1 Global Generic Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Rheumatology
1.3.6 Oncology
1.4 Global Generic Drugs Market by Region
1.4.1 Global Generic Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Generic Drugs Status and Prospect (2012-2022)
1.4.3 China Generic Drugs Status and Prospect (2012-2022)
1.4.4 Europe Generic Drugs Status and Prospect (2012-2022)
1.4.5 Japan Generic Drugs Status and Prospect (2012-2022)
1.4.6 Southeast Asia Generic Drugs Status and Prospect (2012-2022)
1.4.7 India Generic Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Generic Drugs (2012-2022)
1.5.1 Global Generic Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Generic Drugs Revenue and Growth Rate (2012-2022)

2 Global Generic Drugs Competition by Players/Suppliers, Type and Application
2.1 Global Generic Drugs Market Competition by Players/Suppliers
2.1.1 Global Generic Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Generic Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Generic Drugs (Volume and Value) by Type
2.2.1 Global Generic Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Generic Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Generic Drugs (Volume and Value) by Region
2.3.1 Global Generic Drugs Sales and Market Share by Region (2012-2017)
2.3.2 Global Generic Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Generic Drugs (Volume) by Application

3 United States Generic Drugs (Volume, Value and Sales Price)
3.1 United States Generic Drugs Sales and Value (2012-2017)
3.1.1 United States Generic Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Generic Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Generic Drugs Sales Price Trend (2012-2017)
3.2 United States Generic Drugs Sales Volume and Market Share by Players
3.3 United States Generic Drugs Sales Volume and Market Share by Type
3.4 United States Generic Drugs Sales Volume and Market Share by Application

4 China Generic Drugs (Volume, Value and Sales Price)
4.1 China Generic Drugs Sales and Value (2012-2017)
4.1.1 China Generic Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Generic Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Generic Drugs Sales Price Trend (2012-2017)
4.2 China Generic Drugs Sales Volume and Market Share by Players
4.3 China Generic Drugs Sales Volume and Market Share by Type
4.4 China Generic Drugs Sales Volume and Market Share by Application

5 Europe Generic Drugs (Volume, Value and Sales Price)
5.1 Europe Generic Drugs Sales and Value (2012-2017)
5.1.1 Europe Generic Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Generic Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Generic Drugs Sales Price Trend (2012-2017)
5.2 Europe Generic Drugs Sales Volume and Market Share by Players
5.3 Europe Generic Drugs Sales Volume and Market Share by Type
5.4 Europe Generic Drugs Sales Volume and Market Share by Application

6 Japan Generic Drugs (Volume, Value and Sales Price)
6.1 Japan Generic Drugs Sales and Value (2012-2017)
6.1.1 Japan Generic Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Generic Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Generic Drugs Sales Price Trend (2012-2017)
6.2 Japan Generic Drugs Sales Volume and Market Share by Players
6.3 Japan Generic Drugs Sales Volume and Market Share by Type
6.4 Japan Generic Drugs Sales Volume and Market Share by Application

7 Southeast Asia Generic Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Generic Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Generic Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Generic Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Generic Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Generic Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Generic Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Generic Drugs Sales Volume and Market Share by Application

8 India Generic Drugs (Volume, Value and Sales Price)
8.1 India Generic Drugs Sales and Value (2012-2017)
8.1.1 India Generic Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Generic Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Generic Drugs Sales Price Trend (2012-2017)
8.2 India Generic Drugs Sales Volume and Market Share by Players
8.3 India Generic Drugs Sales Volume and Market Share by Type
8.4 India Generic Drugs Sales Volume and Market Share by Application

9 Global Generic Drugs Players/Suppliers Profiles and Sales Data
9.1 Teva Pharma
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Generic Drugs Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Teva Pharma Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Novartis-Sandoz
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Generic Drugs Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Novartis-Sandoz Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Mylan
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Generic Drugs Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Mylan Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Sun Pharmaceutical
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Generic Drugs Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Sun Pharmaceutical Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Aspen Pharmacare
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Generic Drugs Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Aspen Pharmacare Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Allergan
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Generic Drugs Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Allergan Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Fresenius Kabi
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Generic Drugs Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Fresenius Kabi Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Pfizer (Hospira)
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Generic Drugs Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Pfizer (Hospira) Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Sanofi
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Generic Drugs Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Sanofi Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Aurobindo
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Generic Drugs Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Aurobindo Generic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Lupin
9.12 Dr. Reddy’s Lab
9.13 Apotex
9.14 Cipla
9.15 ENDO (Par Pharmaceutical)
9.16 Stada
9.17 Krka Group
9.18 Nichi-Iko Pharmaceutical
9.19 Valeant
9.20 Zydus Cadila
9.21 Hikma

10 Generic Drugs Maufacturing Cost Analysis
10.1 Generic Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Generic Drugs
10.3 Manufacturing Process Analysis of Generic Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Generic Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Generic Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Generic Drugs Market Forecast (2017-2022)
14.1 Global Generic Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Generic Drugs Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Generic Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Generic Drugs Price and Trend Forecast (2017-2022)
14.2 Global Generic Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Generic Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Generic Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Generic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Generic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Generic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Generic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Generic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Generic Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Generic Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Generic Drugs Sales Forecast by Type (2017-2022)
14.3.2 Global Generic Drugs Revenue Forecast by Type (2017-2022)
14.3.3 Global Generic Drugs Price Forecast by Type (2017-2022)
14.4 Global Generic Drugs Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Generic Drugs
Figure Global Generic Drugs Sales Volume Comparison (K MT) by Type (2012-2022)
Figure Global Generic Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Simple Generic Drugs Product Picture
Figure Super Generic Drugs Product Picture
Figure Biosimilars Product Picture
Figure Global Generic Drugs Sales Comparison (K MT) by Application (2012-2022)
Figure Global Sales Market Share of Generic Drugs by Application in 2016
Figure CNS Examples
Figure Cardiovascular Examples
Figure Genitourinary/Hormonal Drugs Examples
Figure Rheumatology Examples
Figure Oncology Examples
Figure Global Generic Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Generic Drugs Sales Volume (K MT) and Growth Rate (2012-2022)
Figure Global Generic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Generic Drugs Sales Volume (K MT) (2012-2017)
Table Global Generic Drugs Sales (K MT) of Key Players/Suppliers (2012-2017)
Table Global Generic Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Generic Drugs Sales Share by Players/Suppliers
Figure 2017 Generic Drugs Sales Share by Players/Suppliers
Figure Global Generic Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Generic Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Generic Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Generic Drugs Revenue Share by Players
Table 2017 Global Generic Drugs Revenue Share by Players
Table Global Generic Drugs Sales (K MT) and Market Share by Type (2012-2017)
Table Global Generic Drugs Sales Share (K MT) by Type (2012-2017)
Figure Sales Market Share of Generic Drugs by Type (2012-2017)
Figure Global Generic Drugs Sales Growth Rate by Type (2012-2017)
Table Global Generic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Generic Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Generic Drugs by Type (2012-2017)
Figure Global Generic Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Generic Drugs Sales Volume (K MT) and Market Share by Region (2012-2017)
Table Global Generic Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Generic Drugs by Region (2012-2017)
Figure Global Generic Drugs Sales Growth Rate by Region in 2016
Table Global Generic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Generic Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Generic Drugs by Region (2012-2017)
Figure Global Generic Drugs Revenue Growth Rate by Region in 2016
Table Global Generic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Generic Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Generic Drugs by Region (2012-2017)
Figure Global Generic Drugs Revenue Market Share by Region in 2016
Table Global Generic Drugs Sales Volume (K MT) and Market Share by Application (2012-2017)
Table Global Generic Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Generic Drugs by Application (2012-2017)
Figure Global Generic Drugs Sales Market Share by Application (2012-2017)
Figure United States Generic Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure United States Generic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Generic Drugs Sales Price (USD/MT) Trend (2012-2017)
Table United States Generic Drugs Sales Volume (K MT) by Players (2012-2017)
Table United States Generic Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Generic Drugs Sales Volume Market Share by Players in 2016
Table United States Generic Drugs Sales Volume (K MT) by Type (2012-2017)
Table United States Generic Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Generic Drugs Sales Volume Market Share by Type in 2016
Table United States Generic Drugs Sales Volume (K MT) by Application (2012-2017)
Table United States Generic Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Generic Drugs Sales Volume Market Share by Application in 2016
Figure China Generic Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure China Generic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Generic Drugs Sales Price (USD/MT) Trend (2012-2017)
Table China Generic Drugs Sales Volume (K MT) by Players (2012-2017)
Table China Generic Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Generic Drugs Sales Volume Market Share by Players in 2016
Table China Generic Drugs Sales Volume (K MT) by Type (2012-2017)
Table China Generic Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Generic Drugs Sales Volume Market Share by Type in 2016
Table China Generic Drugs Sales Volume (K MT) by Application (2012-2017)
Table China Generic Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Generic Drugs Sales Volume Market Share by Application in 2016
Figure Europe Generic Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Generic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Generic Drugs Sales Price (USD/MT) Trend (2012-2017)
Table Europe Generic Drugs Sales Volume (K MT) by Players (2012-2017)
Table Europe Generic Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Generic Drugs Sales Volume Market Share by Players in 2016
Table Europe Generic Drugs Sales Volume (K MT) by Type (2012-2017)
Table Europe Generic Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Generic Drugs Sales Volume Market Share by Type in 2016
Table Europe Generic Drugs Sales Volume (K MT) by Application (2012-2017)
Table Europe Generic Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Generic Drugs Sales Volume Market Share by Application in 2016
Figure Japan Generic Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Japan Generic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Generic Drugs Sales Price (USD/MT) Trend (2012-2017)
Table Japan Generic Drugs Sales Volume (K MT) by Players (2012-2017)
Table Japan Generic Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Generic Drugs Sales Volume Market Share by Players in 2016
Table Japan Generic Drugs Sales Volume (K MT) by Type (2012-2017)
Table Japan Generic Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Generic Drugs Sales Volume Market Share by Type in 2016
Table Japan Generic Drugs Sales Volume (K MT) by Application (2012-2017)
Table Japan Generic Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Generic Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Generic Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure Southeast Asia Generic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Generic Drugs Sales Price (USD/MT) Trend (2012-2017)
Table Southeast Asia Generic Drugs Sales Volume (K MT) by Players (2012-2017)
Table Southeast Asia Generic Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Generic Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Generic Drugs Sales Volume (K MT) by Type (2012-2017)
Table Southeast Asia Generic Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Generic Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Generic Drugs Sales Volume (K MT) by Application (2012-2017)
Table Southeast Asia Generic Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Generic Drugs Sales Volume Market Share by Application in 2016
Figure India Generic Drugs Sales (K MT) and Growth Rate (2012-2017)
Figure India Generic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Generic Drugs Sales Price (USD/MT) Trend (2012-2017)
Table India Generic Drugs Sales Volume (K MT) by Players (2012-2017)
Table India Generic Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Generic Drugs Sales Volume Market Share by Players in 2016
Table India Generic Drugs Sales Volume (K MT) by Type (2012-2017)
Table India Generic Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Generic Drugs Sales Volume Market Share by Type in 2016
Table India Generic Drugs Sales Volume (K MT) by Application (2012-2017)
Table India Generic Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Generic Drugs Sales Volume Market Share by Application in 2016
Table Teva Pharma Basic Information List
Table Teva Pharma Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Teva Pharma Generic Drugs Sales Growth Rate (2012-2017)
Figure Teva Pharma Generic Drugs Sales Global Market Share (2012-2017
Figure Teva Pharma Generic Drugs Revenue Global Market Share (2012-2017)
Table Novartis-Sandoz Basic Information List
Table Novartis-Sandoz Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis-Sandoz Generic Drugs Sales Growth Rate (2012-2017)
Figure Novartis-Sandoz Generic Drugs Sales Global Market Share (2012-2017
Figure Novartis-Sandoz Generic Drugs Revenue Global Market Share (2012-2017)
Table Mylan Basic Information List
Table Mylan Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Mylan Generic Drugs Sales Growth Rate (2012-2017)
Figure Mylan Generic Drugs Sales Global Market Share (2012-2017
Figure Mylan Generic Drugs Revenue Global Market Share (2012-2017)
Table Sun Pharmaceutical Basic Information List
Table Sun Pharmaceutical Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sun Pharmaceutical Generic Drugs Sales Growth Rate (2012-2017)
Figure Sun Pharmaceutical Generic Drugs Sales Global Market Share (2012-2017
Figure Sun Pharmaceutical Generic Drugs Revenue Global Market Share (2012-2017)
Table Aspen Pharmacare Basic Information List
Table Aspen Pharmacare Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Aspen Pharmacare Generic Drugs Sales Growth Rate (2012-2017)
Figure Aspen Pharmacare Generic Drugs Sales Global Market Share (2012-2017
Figure Aspen Pharmacare Generic Drugs Revenue Global Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Allergan Generic Drugs Sales Growth Rate (2012-2017)
Figure Allergan Generic Drugs Sales Global Market Share (2012-2017
Figure Allergan Generic Drugs Revenue Global Market Share (2012-2017)
Table Fresenius Kabi Basic Information List
Table Fresenius Kabi Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Fresenius Kabi Generic Drugs Sales Growth Rate (2012-2017)
Figure Fresenius Kabi Generic Drugs Sales Global Market Share (2012-2017
Figure Fresenius Kabi Generic Drugs Revenue Global Market Share (2012-2017)
Table Pfizer (Hospira) Basic Information List
Table Pfizer (Hospira) Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer (Hospira) Generic Drugs Sales Growth Rate (2012-2017)
Figure Pfizer (Hospira) Generic Drugs Sales Global Market Share (2012-2017
Figure Pfizer (Hospira) Generic Drugs Revenue Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Generic Drugs Sales Growth Rate (2012-2017)
Figure Sanofi Generic Drugs Sales Global Market Share (2012-2017
Figure Sanofi Generic Drugs Revenue Global Market Share (2012-2017)
Table Aurobindo Basic Information List
Table Aurobindo Generic Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Aurobindo Generic Drugs Sales Growth Rate (2012-2017)
Figure Aurobindo Generic Drugs Sales Global Market Share (2012-2017
Figure Aurobindo Generic Drugs Revenue Global Market Share (2012-2017)
Table Lupin Basic Information List
Table Dr. Reddy’s Lab Basic Information List
Table Apotex Basic Information List
Table Cipla Basic Information List
Table ENDO (Par Pharmaceutical) Basic Information List
Table Stada Basic Information List
Table Krka Group Basic Information List
Table Nichi-Iko Pharmaceutical Basic Information List
Table Valeant Basic Information List
Table Zydus Cadila Basic Information List
Table Hikma Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Generic Drugs
Figure Manufacturing Process Analysis of Generic Drugs
Figure Generic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Generic Drugs Major Players in 2016
Table Major Buyers of Generic Drugs
Table Distributors/Traders List
Figure Global Generic Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Global Generic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Generic Drugs Price (USD/MT) and Trend Forecast (2017-2022)
Table Global Generic Drugs Sales Volume (K MT) Forecast by Regions (2017-2022)
Figure Global Generic Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Generic Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Generic Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Generic Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Generic Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Generic Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure United States Generic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Generic Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure China Generic Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Generic Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Europe Generic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Generic Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan Generic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Generic Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Generic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Generic Drugs Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure India Generic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Generic Drugs Sales (K MT) Forecast by Type (2017-2022)
Figure Global Generic Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Generic Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Generic Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Generic Drugs Price (USD/MT) Forecast by Type (2017-2022)
Table Global Generic Drugs Sales (K MT) Forecast by Application (2017-2022)
Figure Global Generic Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[ジェネリック医薬品の世界市場:販売動向2017] (Global Generic Drugs Sales Market Report 2017 / QYR7052211)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆